Skip to main content

Esophageal Cancer Clinical Trials

Review the esophageal cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 101-125 of 139

Yoga Program for Improving the Quality of Life in Couples Coping with Cancer
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
The Vanguard Study: Testing a New Way to Screen for Cancer
Status: Active
Location: 37 locations
An Artificial-Intelligence Mobile High-Resolution Microendoscope for the Screening of Esophageal Cancer
Status: Active
Location: 2 locations
Swallowable Sponge Cell Sampling Device in Screening Patients with Esophageal Cancer Undergoing Esophagogastroduodenoscopy
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Status: Active
Location: 6 locations
Minimally Invasive Screening Tool for the Diagnosis of Barrett’s Esophagus and Esophageal Cancer
Status: Active
Location: 3 locations
Genetic Testing on Blood Samples for Treatment Suggestions in Patients with Advanced or Metastatic Cancer
Status: Active
Location: 3 locations
An Investigational Scan (18F-FAraG PET/CT) for Tumor Detection and Prediction of Treatment Response in Patients with Locally Advanced Esophageal Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors
Status: Active
Location: Montefiore Medical Center-Weiler Hospital, Bronx, New York
New PET Scan (68Ga-FAPI-46) for People with Cancers
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients with Lung or Esophageal Cancer, EUCLID Trial
Status: Active
Location: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
The Cellular Collection Device for Early Detection of Esophageal Squamous Cell Carcinoma
Status: Active
Location: See ClinicalTrials.gov
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Status: Active
Location: Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in Gastrointestinal Cancer, PERICLES Study
Status: Temporarily Closed to Accrual
Location: 2 locations
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Status: Active
Location: 324 locations
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients with Cancer
Status: Active
Location: Virginia K Crosson Cancer Center, Fullerton, California
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
Status: Active
Location: See ClinicalTrials.gov
A Pilot Study to Assess the Functional Capacity of Esophageal and Lung Cancer Patients Receiving Neoadjuvant Therapy
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Collecting Blood Samples from Patients with and without Cancer to Evaluate Tests for Early Cancer Detection
Status: Active
Location: 727 locations
Assessment of Esophageal Distensibility and Mucosal Impedance in Dysplastic Barrett's Esophagus Patients Undergoing Radiofrequency Ablation
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Evaluating Outcomes in Patients with Barrett's Esophagus Undergoing Treatment with Resection and Endoscopic Ablation Techniques, Treat-Be Study
Status: Active
Location: 5 locations
Genetic and Epigenetic Analysis of Gastrointestinal Specimens
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
UNC Barrett's Esophagus and Esophageal Cancer Biorepository (BEECAB)
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-04)
Status: Active
Location: 3 locations
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Status: Active
Location: 7 locations